NCT01575730View on ClinicalTrials.gov

Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 21, 2012

Primary Completion Date

March 18, 2013

Study Completion Date

March 18, 2013

Conditions
Peritoneal Carcinomatosis
Interventions
PROCEDURE

Hyperthermic intraoperative Peritoneal Chemoperfusion

Dose: 460 mg/m², duration: 30 minutes, temperature 37°C

PROCEDURE

Hyperthermic intraoperative Peritoneal Chemoperfusion

Dose: 460 mg/m², duration: 30 minutes, temperature 41°C

DRUG

Hyperthermic intraoperative Peritoneal Chemoperfusion

Dose: 200 mg/m², duration: 90 minutes, temperature 37°C

Trial Locations (1)

Unknown

Ghent University Hospital, Ghent

All Listed Sponsors
collaborator

University Ghent

OTHER

lead

University Hospital, Ghent

OTHER

NCT01575730 - Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis | Biotech Hunter | Biotech Hunter